Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Head of SA Witness Protection Programme pays UFS a visit
2010-05-04

 
Receiving the Head of the South African Witness Protection Programme are, in front: Prof. Hennie Oosthuizen, Head of the Department of Criminal and Medical Law at the UFS; back: Adv. Beatri Kruger from the UFS Unit for Children’s Rights, Ms Lani Opperman, Member of the Free State Human Trafficking Forum (FHF), Adv. John Welch, Head of the Witness Protection Programme in South Africa; and Lene van Zyl, a LLM student at the UFS who is doing her thesis on human trafficking in body parts.
Photo: Leonie Bolleurs


Recently Adv. Beatri Kruger from the Unit for Children’s Rights in the Faculty of Law at the University of the Free State (UFS) invited Adv. John Welch, Head of the Witness Protection Programme in South Africa, to address the Free State Human Trafficking Forum (FHF) on the safe-keeping of victims who are witnesses against human traffickers.

Human trafficking is prevalent in the Free State, especially in Bloemfontein. The Unit for Children’s Rights is one of the founding members of the FHF that was established to take action against and fight the disturbing reality of human trafficking more efficiently.

According to Adv. Kruger the FHF identified the problem of trafficked witnesses being threatened by human trafficker syndicates.

Adv. Welch made some suggestions with regard to the safe-keeping of trafficked victims. He also, with some of the forum members, paid a visit to the areas in Bloemfontein where human trafficking is prevalent as well as to the local shelter for trafficked victims.

Adv. Welch undertook to join forces with the FHF in assisting trafficked victims and the local Witness Protection Programme Office is now a member of the forum.

Since December 2009 members of the FHF managed to disrupt the work of the human trafficking syndicates. “The traffickers have not stopped this inhumane practice but there are indications that they have moved to other buildings in the inner city and even to houses in the suburbs. It was reported to the forum that approximately 27 males suspected of being involved in human trafficking had been arrested, and since they are illegal in the country, they were deported to their countries of origin,” said Adv. Kruger.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept